Skip to main content
FinSpry Logo
FinSpry
MREO logo
MREO
(NASDAQ)
Mereo BioPharma Group plc
$0.29-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Mereo BioPharma Group (MREO) Stock Price & Financial Analysis

Mereo BioPharma Group Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.29 - $0.31
52-Week High$2.37
52-Week Low$0.20
Open$0.29
Volume694.55K
Average Volume (3M)1.45M
Market Cap47.72M
Shares Outstanding160.36M
Price to Sales (P/S)103.53
Price to Book (P/B)1.52
EV/EBITDA-0.43
Revenue (TTM)500.00K
Net Income (TTM)-35.70M
Free Cash Flow (TTM)-27.26M
EPS (TTM)$-0.22
Profit Margin-7139.75%
Operating Margin-7198.26%
Return on Equity (ROE)-104.83%
Debt to Equity0.00
50-Day MA$0.30
200-Day MA$0.86
52-Week Change-81.87%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Mereo BioPharma Group

What is the current stock price for MREO?

As of the latest trading session, MREO stock trades at $0.29. The 52-week range is $0.20–$2.37, with a day range of $0.29–$0.31.

What is the P/E ratio for MREO?

The P/E ratio (Price-to-Earnings) for MREO is shown in the Key Statistics section. This valuation metric helps compare Mereo BioPharma Group plc to industry peers.

Does MREO pay dividends?

Mereo BioPharma Group does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MREO?

Based on 3 analysts, the consensus for MREO is Buy.

What is the market cap of MREO?

Mereo BioPharma Group's market capitalization is $46.7M, classifying it as a micro-cap company. Mereo BioPharma Group operates in the Healthcare sector within the Biotechnology industry.